Abstract
Ablation of atrial fibrillation (AF) has expanded from its limited application for patients with paroxysmal AF and structurally normal hearts to patients with persistent arrhythmia and more extensive structural heart disease. The cornerstone of this procedure involves pulmonary vein (PV) isolation, which is achieved by encircling lesions around the PVs. Success rates are highest for patients with paroxysmal AF, but modification of the technique to include linear lesions in the left atrium and targeting complex electrograms has improved outcomes in patients with long-lasting AF. The procedure remains complex, and the risk of complications must be balanced against the perceived benefit of maintaining sinus rhythm. For this reason, AF ablation is indicated in symptomatic patients who have failed at least one antiarrhythmic drug. Current studies will address catheter ablation’s role as first-line therapy for patients with AF.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Wyse DG, Waldo AL, DiMarco JP, et al.: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002, 347:1825–1833.
Corley SD, Epstein AE, DiMarco JP, et al.: Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004, 109:1509–1513.
Prasad SM, Maniar HS, Camillo CJ, et al.: The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg 2003, 126:1822–1828.
Swartz JF, Pellersels G, Silvers J, et al.: A catheter-based curative approach to atrial-fibrillation in humans [abstract]. Circulation 1994, 90:335.
Haissaguerre M, Jais P, Shah DC, et al.: Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1996, 7:1132–1144.
Haissaguerre M, Jais P, Shah DC, et al.: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998, 339:659–666.
Hocini M, Haissaguerre M, Shah D, et al.: Multiple sources initiating atrial fibrillation from a single pulmonary vein identified by a circumferential catheter. Pacing Clin Electrophysiol 2000, 23:1828–1831.
Haissaguerre M, Jais P, Shah DC, et al.: Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000, 101:1409–1417.
Haissaguerre M, Shah DC, Jais P, et al.: Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000, 102:2463–2465.
Ho SY, Cabrera JA, Tran VH, et al.: Architecture of the pulmonary veins: relevance to radiofrequency ablation. Heart 2001, 86:265–270.
de Bakker JM, Ho SY, Hocini M: Basic and clinical electrophysiology of pulmonary vein ectopy. Cardiovasc Res 2002, 54:287–294.
Patterson E, Po SS, Scherlag BJ, Lazzara R: Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm 2005, 2:624–631.
Arora R, Verheule S, Scott L, et al.: Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation 2003, 107:1816–1821.
Mandapati R, Skanes A, Chen J, et al.: Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 2000, 101:194–199.
Kanj M, Wazni O, Natale A: Pulmonary vein antrum isolation. Heart Rhythm 2007, 4:S73–S79.
Pappone C, Rosanio S, Oreto G, et al.: Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 2000, 102:2619–2628.
Nademanee K, McKenzie J, Kosar E, et al.: A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004, 43:2044–2053.
Haissaguerre M, Sanders P, Hocini M, et al.: Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol 2005, 16:1125–1137.
Jais P, Hocini M, Hsu LF, et al.: Technique and results of linear ablation at the mitral isthmus. Circulation 2004, 110:2996–3002.
Pappone C, Santinelli V, Manguso F, et al.: Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004, 109:327–334.
Scherlag BJ, Nakagawa H, Jackman WM, et al.: Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation. J Interv Card Electrophysiol 2005, 13(Suppl 1):37–42.
Lin J, Scherlag BJ, Zhou J, et al.: Autonomic mechanism to explain complex fractionated atrial electrograms (CFAE). J Cardiovasc Electrophysiol 2007, 18:1197–1205.
Haissaguerre M, Hocini M, Sanders P, et al.: Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 2005, 16:1138–1147.
Ouyang F, Ernst S, Chun J, et al.: Electrophysiological findings during ablation of persistent atrial fibrillation with electroanatomic mapping and double Lasso catheter technique. Circulation 2005, 112:3038–3048.
Oral H, Knight BP, Ozaydin M, et al.: Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol 2002, 40:100–104.
Neumann T, Erdogan A, Dill T, et al.: Asymptomatic recurrences of atrial fibrillation after pulmonary vein isolation. Europace 2006, 8:495–498.
Wazni OM, Marrouche NF, Martin DO, et al.: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005, 293:2634–2640.
Pappone C, Augello G, Sala S, et al.: A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 2006, 48:2340–2347.
Jais P, Cauchemez B, MacLe L, et al.: Atrial fibrillation ablation vs antiarrhythmic drugs: a multicenter randomized trial [abstract]. Heart Rhythm 2006, 3(Suppl):S460.
Oral H, Pappone C, Chugh A, et al.: Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006, 354:934–941.
Stabile G, Bertaglia E, Senatore G, et al.: Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J 2006, 27:216–221.
Pappone C, Rosanio S, Augello G, et al.: Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003, 42:185–197.
Cappato R, Calkins H, Chen SA, et al.: Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005, 111:1100–1105.
Saad EB, Rossillo A, Saad CP, et al.: Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy. Circulation 2003, 108:3102–3107.
Pappone C, Oral H, Santinelli V, et al.: Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 2004, 109:2724–2726.
Patel A, Au E, Donegan K, et al.: Multidetector row computed tomography for identification of left atrial appendage filling defects in patients undergoing pulmonary vein isolation for treatment of atrial fibrillation: comparison with transesophageal echocardiography. Heart Rhythm 2008, 5:253–260.
Calkins H, Brugada J, Packer DL, et al.: HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007, 4:816–861.
Mesas CE, Pappone C, Lang CC, et al.: Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment. J Am Coll Cardiol 2004, 44:1071–1079.
Gerstenfeld EP, Marchlinski FE: Mapping and ablation of left atrial tachycardias occurring after atrial fibrillation ablation. Heart Rhythm 2007, 4:S65–S72.
Nademanee K, Schwab MC, Kosar EM, et al.: Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol 2008, 51:843–849.
Hsu LF, Jais P, Sanders P, et al.: Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004, 351:2373–2383.
Kilicaslan F, Verma A, Saad E, et al.: Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. Heart Rhythm 2006, 3:275–280.
Khaykin Y, Marrouche NF, Saliba W, et al.: Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery. Heart Rhythm 2004, 1:33–39.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Markowitz, S.M. Ablation of atrial fibrillation: Patient selection, technique, and outcome. Curr Cardiol Rep 10, 360–366 (2008). https://doi.org/10.1007/s11886-008-0058-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11886-008-0058-5